These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8149272)

  • 41. [D-penicillamine therapy of chronic polyarthritis].
    Günther R; Gabl F; Knapp E
    Z Rheumaforsch; 1973; 32(7):313-25. PubMed ID: 4741805
    [No Abstract]   [Full Text] [Related]  

  • 42. [Clinical and prognostic significance of antinuclear factors during D-penicillamine treatment (author's transl)].
    Helmke K; Velcovsky HG; Federlin K
    Dtsch Med Wochenschr; 1975 Oct; 100(43):2198-203. PubMed ID: 1080704
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Unilateral ptosis as an initial manifestation of D-penicillamine induced myasthenia gravis.
    Raynauld JP; Lee YS; Kornfeld P; Fries JF
    J Rheumatol; 1993 Sep; 20(9):1592-3. PubMed ID: 8164222
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Morphology and pathogenesis of penicillamine-induced nephropathy].
    Henzgen S; Waldmann G
    Zentralbl Allg Pathol; 1983; 128(1-2):53-61. PubMed ID: 6637187
    [TBL] [Abstract][Full Text] [Related]  

  • 45. D-penicillamine in the treatment of rheumatoid arthritis and progressive systemic sclerosis.
    Davis P; Bleehen SS
    Br J Dermatol; 1976 Jun; 94(6):705-11. PubMed ID: 779821
    [No Abstract]   [Full Text] [Related]  

  • 46. [Cholestatic hepatitis: a rare complication of the treatment with D. penicillamine].
    Berbis P; Fabre JF; Privat Y
    Ann Dermatol Venereol; 1987; 114(3):377-9. PubMed ID: 3605968
    [No Abstract]   [Full Text] [Related]  

  • 47. Penicillamine for scleroderma.
    Fulghum DD; Katz R
    Arch Dermatol; 1968 Jul; 98(1):51-2. PubMed ID: 5241672
    [No Abstract]   [Full Text] [Related]  

  • 48. Penicillamine-induced myasthenia gravis in progressive systemic sclerosis.
    Torres CF; Griggs RC; Baum J; Penn AS
    Arthritis Rheum; 1980 Apr; 23(4):505-8. PubMed ID: 7370063
    [No Abstract]   [Full Text] [Related]  

  • 49. Breast enlargement induced by D-penicillamine.
    Tchebiner JZ
    Ann Pharmacother; 2002 Mar; 36(3):444-5. PubMed ID: 11895058
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anti-MuSK- and anti-AChR-positive myasthenia gravis induced by d-penicillamine.
    Poulas K; Koutsouraki E; Kordas G; Kokla A; Tzartos SJ
    J Neuroimmunol; 2012 Sep; 250(1-2):94-8. PubMed ID: 22683336
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Proteinuria in immunopathological diseases during long-term penicillamine therapy (author's transl)].
    Hrncír Z; Tichý M
    Cas Lek Cesk; 1976 May; 115(18):549-51. PubMed ID: 1277236
    [No Abstract]   [Full Text] [Related]  

  • 52. Decreased taste sensitivity after D-penicillamine reversed by copper administration.
    Henkin RI; Keiser HR; Jafee IA; Sternlieb I; Scheinberg IH
    Lancet; 1967 Dec; 2(7529):1268-71. PubMed ID: 4168610
    [No Abstract]   [Full Text] [Related]  

  • 53. [Cholestatic jaundice induced by D-penicillamine and oral steroid contraceptive in progressive systemic sclerosis (author's transl)].
    Wozel G; Julius U
    Dtsch Z Verdau Stoffwechselkr; 1982; 42(2-3):85-93. PubMed ID: 6179735
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nephropathy induced by D-penicillamine.
    Jaffe IA; Treser G; Suzuki Y; Ehrenreich T
    Ann Intern Med; 1968 Sep; 69(3):549-56. PubMed ID: 4175137
    [No Abstract]   [Full Text] [Related]  

  • 55. D-penicillamine treatment of progressive systemic sclerosis (scleroderma): a comparison of clinical and in vitro effects.
    Shapiro LS; Prince RK; Buckingham RB; Rodnan GP
    J Rheumatol; 1983 Apr; 10(2):316-8. PubMed ID: 6864687
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Asymptomatic annular plaques on the neck.
    Chabra IS; Grandinetti LM
    Cutis; 2014 Oct; 94(4):E1-3. PubMed ID: 25372260
    [No Abstract]   [Full Text] [Related]  

  • 57. Loss of taste during therapy with penicillamine.
    Keiser HR; Henkin RI; Bartter FC; Sjoerdsma A
    JAMA; 1968 Feb; 203(6):381-3. PubMed ID: 5694119
    [No Abstract]   [Full Text] [Related]  

  • 58. Monoclonal gammopathy penicillamine-induced polymyositis and systemic sclerosis.
    Nishikai M; Funatsu Y; Homma M
    Arch Dermatol; 1974 Aug; 110(2):253-5. PubMed ID: 4853253
    [No Abstract]   [Full Text] [Related]  

  • 59. Penicillamine therapy in systemic sclerosis.
    Jayson MI; Lovell C; Black CM; Wilson RS
    Proc R Soc Med; 1977; 70 Suppl 3(Suppl 3):82-8. PubMed ID: 122683
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Penicillamine in the treatment of scleroderma. Lathyrogenic drugs].
    Szczepanski A
    Przegl Dermatol; 1971; 58(3):355-9. PubMed ID: 4944035
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.